› Forums › Caregiver Community › Possible Upcoming ODAC Meeting
- This topic is empty.
- Post
-
- February 23, 2017 at 10:02 pm
Dear MPIP Community:
FDA's Oncologic Drugs Advisory Committee (ODAC) will meet very soon to discuss an investigational new melanoma drug. This meeting will include an opportunity for NRAS mutant patients (and caregivers of those patients) to speak to the committee about the importance of new treatment options in metastatic melanoma. The FDA also allows letters to be written. We encourage you to get involved the best way you can.
If either of these opportunities would be of interest to you, please email me directly at [email protected]. Once the FDA provides a date for the meeting, we'll know more details on both the meeting and the letter writing opportunity, so stay tuned.
Thank you,
Shelby – MRF
Tagged: caregiver
- You must be logged in to reply to this topic.